
This is great news. But I am not convinced that it’s quite as significant as many are making out. 1. The news cycle at the moment is WILD. Yes it’s big news if you work in the industry and feels exciting, but outside of that it’s a story that lasts a few hours then vanishes. 2. Its success will depend on the end product, not just the fact it’s a big name. If they target an older aging population they will need wide variety of products and imo novel methods not flower. 3. Big corporations that enter the medical cannabis space are often guided by hyper merchants. They mean well to some extent but the prevailing message is one of how amazing the opportunity is rather than the quantity of the offer to patients. 4. The advertising restrictions make unlocking the 65+ demographic unbelievably challenging. It will take a whole lot more than Boots simply bring in the game. Still great news, big win! But seen a few people on social media frame this as “biggest thing to happen in medical cannabis globally” 😬 volteface.uk/boots-launches-…









